117 related articles for article (PubMed ID: 11205888)
21. Effects of redox reagents and arsenical compounds on [3H]-cytisine binding to immunoisolated nicotinic acetylcholine receptors from chick brain containing alpha 4 beta 2 subunits.
Rossant CJ; Lindstrom J; Loring RH
J Neurochem; 1994 Apr; 62(4):1368-74. PubMed ID: 8133267
[TBL] [Abstract][Full Text] [Related]
22. Human nicotinic receptors in chromaffin cells: characterization and pharmacology.
Albillos A; McIntosh JM
Pflugers Arch; 2018 Jan; 470(1):21-27. PubMed ID: 29058146
[TBL] [Abstract][Full Text] [Related]
23. Sigma-1 receptor ligands inhibit catecholamine secretion from adrenal chromaffin cells due to block of nicotinic acetylcholine receptors.
Brindley RL; Bauer MB; Hartley ND; Horning KJ; Currie KPM
J Neurochem; 2017 Oct; 143(2):171-182. PubMed ID: 28815595
[TBL] [Abstract][Full Text] [Related]
24. Receptor protection studies comparing recombinant and native nicotinic receptors: Evidence for a subpopulation of mecamylamine-sensitive native alpha3beta4* nicotinic receptors.
Free RB; Kaser DJ; Boyd RT; McKay DB
Neurosci Lett; 2006 Jan; 392(1-2):135-9. PubMed ID: 16198480
[TBL] [Abstract][Full Text] [Related]
25. Ibogaine acts at the nicotinic acetylcholine receptor to inhibit catecholamine release.
Mah SJ; Tang Y; Liauw PE; Nagel JE; Schneider AS
Brain Res; 1998 Jun; 797(1):173-80. PubMed ID: 9630615
[TBL] [Abstract][Full Text] [Related]
26. Chemical modification and reactivity of sulfhydryls and disulfides of rat brain nicotinic-like acetylcholine receptors.
Lukas RJ; Bennett EL
J Biol Chem; 1980 Jun; 255(12):5573-7. PubMed ID: 7380827
[No Abstract] [Full Text] [Related]
27. Sulfhydryl modification of two nicotinic binding sites in mouse brain.
Stitzel JA; Campbell SM; Collins AC; Marks MJ
J Neurochem; 1988 Mar; 50(3):920-8. PubMed ID: 3339366
[TBL] [Abstract][Full Text] [Related]
28. Effects of oxidizing and reducing analogs of acetylcholine on neuronal nicotinic receptors.
Xie Y; Jones GS; Loring RH
Mol Pharmacol; 1992 Aug; 42(2):356-63. PubMed ID: 1301068
[TBL] [Abstract][Full Text] [Related]
29. Alpha-conotoxin ImI inhibits the alpha-bungarotoxin-resistant nicotinic response in bovine adrenal chromaffin cells.
Broxton NM; Down JG; Gehrmann J; Alewood PF; Satchell DG; Livett BG
J Neurochem; 1999 Apr; 72(4):1656-62. PubMed ID: 10098874
[TBL] [Abstract][Full Text] [Related]
30. Ibogaine selectively inhibits nicotinic receptor-mediated catecholamine release.
Schneider AS; Nagel JE; Mah SJ
Eur J Pharmacol; 1996 Dec; 317(2-3):R1-2. PubMed ID: 8997631
[TBL] [Abstract][Full Text] [Related]
31. Mutations of a conserved lysine residue in the N-terminal domain of alpha7 nicotinic receptors affect gating and binding of nicotinic agonists.
Criado M; Mulet J; Bernal JA; Gerber S; Sala S; Sala F
Mol Pharmacol; 2005 Dec; 68(6):1669-77. PubMed ID: 16129734
[TBL] [Abstract][Full Text] [Related]
32. Nicotinic receptor activation by epibatidine induces heme oxygenase-1 and protects chromaffin cells against oxidative stress.
Egea J; Rosa AO; Cuadrado A; García AG; López MG
J Neurochem; 2007 Sep; 102(6):1842-1852. PubMed ID: 17540012
[TBL] [Abstract][Full Text] [Related]
33. Effects of ginseng saponins on responses induced by various receptor stimuli.
Tachikawa E; Kudo K; Harada K; Kashimoto T; Miyate Y; Kakizaki A; Takahashi E
Eur J Pharmacol; 1999 Mar; 369(1):23-32. PubMed ID: 10204677
[TBL] [Abstract][Full Text] [Related]
34. Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists.
Bergmeier SC; Lapinsky DJ; Free RB; McKay DB
Bioorg Med Chem Lett; 1999 Aug; 9(15):2263-6. PubMed ID: 10465558
[TBL] [Abstract][Full Text] [Related]
35. Substance P modulates the time course of nicotinic but not muscarinic catecholamine secretion from perfused adrenal glands of rat.
Zhou XF; Marley PD; Livett BG
Br J Pharmacol; 1991 Sep; 104(1):159-65. PubMed ID: 1723914
[TBL] [Abstract][Full Text] [Related]
36. Inhibition by pregnenolone sulfate of nicotinic acetylcholine response in adrenal chromaffin cells.
Kudo K; Tachikawa E; Kashimoto T
Eur J Pharmacol; 2002 Dec; 456(1-3):19-27. PubMed ID: 12450565
[TBL] [Abstract][Full Text] [Related]
37. Covalent modification of engineered cysteines in the nicotinic acetylcholine receptor agonist-binding domain inhibits receptor activation.
McLaughlin JT; Hawrot E; Yellen G
Biochem J; 1995 Sep; 310 ( Pt 3)(Pt 3):765-9. PubMed ID: 7575408
[TBL] [Abstract][Full Text] [Related]
38. Brain α4β2 nicotinic acetylcholine receptors are involved in the secretion of noradrenaline and adrenaline from adrenal medulla in rats.
Shimizu T; Tanaka K; Hasegawa T; Yokotani K
Eur J Pharmacol; 2011 Mar; 654(3):241-8. PubMed ID: 21237150
[TBL] [Abstract][Full Text] [Related]
39. Characterization and localization of adrenal nicotinic acetylcholine receptors: evidence that mAb35-nicotinic receptors are the principal receptors mediating adrenal catecholamine secretion.
Gu H; Wenger BW; Lopez I; McKay SB; Boyd RT; McKay DB
J Neurochem; 1996 Apr; 66(4):1454-61. PubMed ID: 8627298
[TBL] [Abstract][Full Text] [Related]
40. Effects of methyllycaconitine and related analogues on bovine adrenal alpha3beta4* nicotinic acetylcholine receptors.
Bryant DL; Free RB; Thomasy SM; Lapinsky DJ; Ismail KA; Arason KM; Bergmeier SC; McKay DB
Ann N Y Acad Sci; 2002 Oct; 971():139-41. PubMed ID: 12438104
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
